General Abstract Information

If you have a change of email address please contact info@sri-online.org as we only communicate notifications via email.

Emails are only sent to the primary/first author of the abstract submission.

Learn more about Late Breaking Abstract Submission here.

ABSTRACT SUBMISSION IS NOW CLOSED!

UPDATE 12/21/2023: Abstract notifications for the Society for Reproductive Investigation's 71st Annual Scientific Meeting have been sent!

Abstract notifications will be sent by email from CTI Meeting Technology, the abstract processor for SRI, by December 31, 2023. Contact authors should add @support.ctimeetingtech.com to their safe senders list to ensure they receive the email.

If you have a change of email address please contact info @sri-online.org as we only communicate notifications via email.
Emails are only sent to the primary/first author of the abstract submission.

Abstract Submission Guidelines

You do not need to be a member of SRI to submit an abstract.
A non-refundable processing fee of $50.00 (US) is required for each abstract. Payment must be completed online using Visa, Mastercard, Discover, or American Express to complete the submission process.
Three (3) keywords for each abstract will be included.
You are allotted 2,700 characters, which will include your Abstract Title, Abstract Body, Authors/Institutions. The allotted characters do not include white space. Figures and Tables will not be accepted for 2024.
Please review the SRI Policy on Abstract Withdrawal and confirm compliance on the Questionnaire page.
The expectation when an abstract is submitted, is that the submitting author will be in attendance either at their poster, or oral.
If accepted for presentation at the meeting, the abstract will be published as entered into the 2024 Annual Meeting Program. However, the Editors reserve the right to edit any abstract that contains grammatical errors.
Each submitted abstract will be reviewed by 4-6 expert reviewers, scored according to criteria described below, and 15% of the accepted abstracts will be chosen for oral presentation. Please note that as the SRI Program Committee is committed to maintaining high standards for the meeting, it is anticipated that a number of low-ranking abstracts will be rejected following peer-review.
Case Reports are not generally encouraged for submission as abstracts unless they significantly advance the field of Reproductive Science.

The SRI will not be held responsible for abstract submissions not received via the website or for submission errors caused by internet service outages, hardware or software delays, power outages or unforeseen events.

Abstract Categories

SRI will continue to accept the following abstract category topics:

Basic Parturition, Prematurity
Gynecology
Clinical Perinatology
Developmental Programming
Fetus
Gynecologic Oncology
Maternal Biology and Health
Placenta
Preeclampsia, Related Disorders
Reproductive Endocrinology
Reproductive Biology
Population Health & Global Health
COVID-19

In-Training Verification Form

In order to qualify for the In Training travel awards and for In Training oral and poster award prizes you must verify your status by uploading a Verification Form during the abstract submission process.

You are an Investigator In Training if you fulfill the following two criteria:

You fall into one of the following categories:

Clinical Fellow in an approved training program, specialty research fellow (Ex: (WRHR, RSDP)
Postdoctoral Fellow within six years of receiving doctoral or senior degree
Resident
Student: Full-time students enrolled in a formal training program leading to a degree (BA, BS, MD, PhD, MS, MPH)
Postgraduate Research Trainee: Individuals within three years of receiving their bachelor’s or master’s degree engaged in a predoctoral research experience (i.e. Postbaccalaureate Intramural Research Training Award (IRTA/CRTA) Program)

You do not currently hold and have never held a faculty position or equivalent in any country.

Early Career Researcher: Someone within their first five (5) years of a faculty or faculty equivalent position. Additionally, should an individual go on parental, health, or any other type of leave, that will not count against the five (5) years.

One may not be both an Early Career Researcher, and In Training.

The following form must be completed by all In Training Presenters whether or not you would like to be eligible for an award.

In Training Verification Form - Word Doc

In Training Verification Form - PDF

The letter must be uploaded during the abstract submission process or emailed to info@sri-online.org as a PDF or Word Document.

Previously Presented Abstracts

Abstracts cannot contain data previously presented at a national or international meeting at the time of abstract submission.
Abstracts cannot contain data already accepted for publication in any online or PubMed indexed venue at the time of abstract submission.
Violators will be subject to abstract withdrawal, and may be barred from presenting at future SRI meetings.

Evaluation of abstracts will be based on the following considerations:

Originality/Innovation: Is the idea or approach novel or is the work primarily confirmatory and/or a direct extension of previous work?
Significance/Relevance: Does the work address an important problem?
Objective/Hypothesis: Is an objective, specific research question and/or hypothesis stated?
Methods: Are the methods described? Are the methods employed appropriate to the research question? Were new methods used and validated?
Results: Are the results described clearly and succinctly? Was data evaluated statistically?
Discussion: Is the conclusion supported by the data

Abstract Notifications:

Abstract notifications will be sent by email from CTI Meeting Technology, the abstract processor for SRI, by December 31, 2023. Contact authors should add @support.ctimeetingtech.com to their safe senders list to ensure they receive the email.

If you have a change of email address please contact sri@support.ctimeetingtech.com as we only communicate notifications via email. Emails are only sent to the primary/first author of the abstract submission.